MedTrace Logo

Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy

NCT05824520 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1066

Last updated 2026-02-02

No results posted yet for this study

Summary

The overall purpose of ACCURATE II trial is to compare the clinical outcomes of CT-derived FFR guided strategy versus medical therapy in patients with chronic coronary syndrome.

Conditions

Interventions

OTHER

ITS plus OMT

Invasive treatment strategy plus optimal medical therapy

OTHER

OMT

Optimal medical therapy alone

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Jian'an Wang, MD · Second Affiliated Hospital, School of Medicine, Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2028-10-20
Completion
2032-10-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05824520 on ClinicalTrials.gov